Buscar
Envista Holdings Corp
NVSTAñadir a la lista de seguimiento
27.310USD
-0.460-1.66%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
4.44BCap. mercado
66.37P/E TTM
Más Datos de Envista Holdings Corp Compañía
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Información de Envista Holdings Corp
Símbolo de cotizaciónNVST
Nombre de la empresaEnvista Holdings Corp
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoKeel (Paul A)
Número de empleados12300
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
Dirección200 S. Kraemer Blvd., Bldg. E
CiudadBREA
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal92821
Teléfono17148175418
Sitio Webhttps://envistaco.com/en
Símbolo de cotizaciónNVST
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoKeel (Paul A)
Ejecutivos de Envista Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
42.49K
+21.96%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Envista Holdings Corp?
Los cinco principales accionistas de Envista Holdings Corp son: Mr. Paul A. Keel
¿Cuántas instituciones poseen acciones de Envista Holdings Corp (NVST)?
A fecha de 2026Q1, 711 instituciones poseen acciones de Envista Holdings Corp, con un valor de mercado combinado de aproximadamente 203.45M, lo que representa el 125.03% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -3285874.00.